TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Why Canopy Growth Corp. Investors Could Get Smoked
Investing
Should Philip Morris International Inc. Buy Canopy Growth Corp.?
Investing
Canopy Growth Corp.: Ignore the Noise and Enjoy the Snowball
Investing
Why Canopy Growth Corp. May Still Be Worth 89 Cents
Investing
Why I’d Buy Canopy Growth Corp. at $7
Investing
Canopy Growth Corp.’s Margins Are About to Be Squeezed
Investing
When Should You Invest in Canopy Growth Corp.?
Investing
Canopy Growth Corp.: How Low Could it Go?
Investing
Will Canopy Growth Corp. Crash as Hard as Valeant Pharmaceuticals Intl Inc.?
Investing
Canopy Growth Corp.: Look Out Below?